Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$1.2M
Net $721.6K sold
Sales
$721.6K
3 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Quart Barry D
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Feb 4, 2026
- Transaction Date
- Feb 2, 2026
- Accession Number
- 0001384243-26-000002
- Form Type
- 4
- Net Trading Amount
- -$721.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Class A Ordinary Share | 830 | $15.47 | Exercise | $12.8K |
| Feb 2, 2026 | Class A Ordinary Share | 830 | $45.00 | Sale | $37.4K |
| Feb 3, 2026 | Class A Ordinary Share | 12,528 | $15.47 | Exercise | $193.8K |
| Feb 3, 2026 | Class A Ordinary Share | 12,528 | $45.27 | Sale | $567.1K |
| Feb 4, 2026 | Class A Ordinary Share | 2,602 | $15.47 | Exercise | $40.3K |
| Feb 4, 2026 | Class A Ordinary Share | 2,602 | $45.02 | Sale | $117.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Derivative | 830 | $15.47 | Exercise | $12.8K |
| Feb 3, 2026 | Derivative | 12,528 | $15.47 | Exercise | $193.8K |
| Feb 4, 2026 | Derivative | 2,602 | $15.47 | Exercise | $40.3K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.02. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F4)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.05. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F5)The option is fully vested and exercisable.